@jackiebrenner

5 posts audited · 18 claims analysed

Instagram profile

Science evidence grade

42%Low evidence grade

Based on 18 claims across 5 audits

SupportedOverstatedMisleadingNo Evidence

7

Supported

39%

1

Overstated

6%

0

Misleading

0%

10

No Evidence

56%

Share this evidence grade

Claim-level evidence grades — not a character judgment. Methodology · Right of reply · Leaderboards

What @jackiebrenner claims actually are

We separate claims into three buckets: backed by evidence, factually incorrect, and grey — like animal-only findings sold as human fact (e.g. BPC-157 “fixes Achilles” from rat studies).

Evidence-based

39%

7 claims

Claims that align with published human or clinical evidence at the stated strength.

Ex: “Semaglutide can reduce body weight in adults with obesity” — supported by large RCTs.

Factually incorrect

0%

0 claims

Claims that conflict with the evidence, invent certainty, or omit critical safety/context in a misleading way.

Ex: “Peptides have no side effects” — contradicts known adverse-event profiles.

Grey / overstated

61%

11 claims

Plausible direction but wrong certainty — animal-only data sold as human fact, dose/effect overstated, or no adequate published support yet.

Ex: “BPC-157 fixes Achilles tears” — often rests on rodent tendon models, not proven human Achilles repair trials.

Evidence mix

Share of audited claims in each bucket

Loading…
BackedIncorrectGrey

Verdict detail

Grey splits into overstated (wrong certainty) vs no published support

Loading…

Claims over time

Stacked by bucket as audits land — plus the running evidence grade

Loading…

Gold line = running science evidence grade (Supported + ½ Overstated ÷ total claims).

Audit history(5 posts)

Post thumbnail
No Evidence
Audited Mar 3, 2026·5 months ago·View source

peptide number 4 - this is going to be 3 parts … but each are there own video #wellness #health #medicine #information #peptide

The claims about BPC-157 and TB4 injections lack scientific substantiation. No credible human clinical trials or peer-reviewed studies were found to support the proposed benefits of these peptide treatments for knee pain, mobility, or sleep improvement.

Post thumbnail
Supported
Audited Mar 3, 2026·5 months ago·View source

peptide number 4 - this is going to be 3 parts … but each are there own video #wellness #health #medicine #information #peptide

The claims about BPC-157 injections lack scientific substantiation. No registered clinical trials or published studies could be found to support the specific patient outcomes described. Further rigorous research is needed to validate these claims.

Post thumbnail
⚠️ Overstated
Audited Mar 3, 2026·5 months ago·View source

peptide number 4 - this is going to be 3 parts … but each are there own video #wellness #health #medicine #information #peptide

The claims about BPC-157 knee injections lack scientific substantiation. No clinical trials or peer-reviewed studies were found to support the proposed benefits. More rigorous research is needed to validate these therapeutic claims.

Post thumbnail
No Evidence
Audited Mar 1, 2026·5 months ago·View source

They are cookin Follow @commonplacehealth for updates on education resources / peptide stuff soon #health #news #wellness #science #medicine

The claims about a peptide called GGG UBT 251 and its weight loss effects appear to be entirely fabricated. No scientific literature or clinical trials could be found to support any of the specific claims made about this alleged peptide.

Post thumbnail
Supported
Posted Feb 25, 2026·5 months ago·View source

They are cookin Follow @commonplacehealth for updates on education resources / peptide stuff soon #health #news #wellness #science #medicine

Four of five claims are directly supported by published clinical trial data or trial design papers in peer-reviewed journals (Diabetes Care, Diabetes Obesity & Metabolism). Retatrutide's Phase 2 and Phase 3 weight loss results (15–28.7%), dose-dependent effects, multi-indication TRIUMPH trial structure, and sustained weight loss over time are all documented in the medical literature. The single unsupported claim regarding Novo's UBT-251 candidate lacks any retrievable published data, preventing verification but not contradicting it. The creator's claims align with current clinical evidence for retatrutide and reflect accurately the trial designs published by Eli Lilly investigators.

Audit another post from @jackiebrenner

Paste their social post link to add a new audit

New audit